Cancer research is one of the most fascinating and demanding industries in the world today. A lot of preparation, research and work goes into each and every product that hits the market. It’s basically a life or death situation for many people and this company is on the ball every hour of the day. Seattle Genetics, located in Bothell, Washington, is the industry’s leader in cancer fighting drugs. The company has well over 1,000 employees, and it’s one of the Pacific Northwest’s biggest employers. Seattle Genetics has revolutionized cancer research in many different ways. Its advanced drugs are some of the most profitable cancer fighting drugs in history, and the company hosts one of the biggest names of the community.
President, Founder, and CEO Clay Siegall has been steering this huge ship to success thanks to his leadership, passion and vision. He knows exactly where the business should be at a specific time. Siegall is a well accomplished doctor as well as a scientist. The guy has many titles and multiple advanced degrees. This includes a Ph.D in Genetics and a B.S. in Zoology. Thanks to George Washington University and the University of Maryland, this man is blessing the world with some fine knowledge. Siegall’s long tenure in the industry didn’t come by chance. He has worked his way of the corporate ladder and now society gets to benefit from his strong work ethic. The same work ethic that goes into each and every product. He’s literally a lifesaver, but he’s also too humble to ever admit it.
Siegall does a lot of blogging when he has the time. These blog posts stretch across a broad spectrum. Some of his latest posts includes the criticism that’s been surrounding the Paris Agreement. He’s also talked about sustainability and President Trump’s actions while in office. All in all, Clay Siegall is human. Expect bigger and better things from Seattle Genetics in the future as well as the guy that control its destiny.